10-ShogaolCAS# 36752-54-2 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 36752-54-2 | SDF | Download SDF |
PubChem ID | 6442612 | Appearance | Yellowish - brown viscous liquid |
Formula | C21H32O3 | M.Wt | 332.5 |
Type of Compound | Phenols | Storage | Desiccate at -20°C |
Solubility | Soluble in chloroform and methanol; insoluble in water | ||
Chemical Name | (E)-1-(4-hydroxy-3-methoxyphenyl)tetradec-4-en-3-one | ||
SMILES | CCCCCCCCCC=CC(=O)CCC1=CC(=C(C=C1)O)OC | ||
Standard InChIKey | FADFGCOCHHNRHF-VAWYXSNFSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 10-Shogaol, as an antioxidant for human skin cell growth and a migration enhancer with potential to be a novel wound repair agent. 2. 8- and 10-Shogaol have similar metabolic profiles to [6]-shogaol and exhibit similar toxicity toward human colon cancer cells. |
Targets | TGF-β/Smad | PDGFR | VEGFR |
10-Shogaol Dilution Calculator
10-Shogaol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.0075 mL | 15.0376 mL | 30.0752 mL | 60.1504 mL | 75.188 mL |
5 mM | 0.6015 mL | 3.0075 mL | 6.015 mL | 12.0301 mL | 15.0376 mL |
10 mM | 0.3008 mL | 1.5038 mL | 3.0075 mL | 6.015 mL | 7.5188 mL |
50 mM | 0.0602 mL | 0.3008 mL | 0.6015 mL | 1.203 mL | 1.5038 mL |
100 mM | 0.0301 mL | 0.1504 mL | 0.3008 mL | 0.6015 mL | 0.7519 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- AR-M 1896
Catalog No.:BCC5931
CAS No.:367518-31-8
- Lurasidone HCl
Catalog No.:BCC4458
CAS No.:367514-88-3
- Lurasidone
Catalog No.:BCC9013
CAS No.:367514-87-2
- Boc-D-Phe-Osu
Catalog No.:BCC2600
CAS No.:3674-18-8
- Boc-Phe-Osu
Catalog No.:BCC2601
CAS No.:3674-06-4
- Beta-Solamarine
Catalog No.:BCN2693
CAS No.:3671-38-3
- 8-Shogaol
Catalog No.:BCN3266
CAS No.:36700-45-5
- Benzyl 2,4-dihydroxyphenyl ketone
Catalog No.:BCC8867
CAS No.:3669-41-8
- Isorhamnetin 3-glucuronide
Catalog No.:BCN2709
CAS No.:36687-76-0
- Pulchinenoside E
Catalog No.:BCN8165
CAS No.:366814-43-9
- Cussosaponin C
Catalog No.:BCN2895
CAS No.:366814-42-8
- Rivaroxaban
Catalog No.:BCC2292
CAS No.:366789-02-8
- 4-Aminophthalimide
Catalog No.:BCC8689
CAS No.:3676-85-5
- MRS 2279
Catalog No.:BCC5880
CAS No.:367909-40-8
- Ribavirin
Catalog No.:BCC4935
CAS No.:36791-04-5
- Vitexin
Catalog No.:BCN5423
CAS No.:3681-93-4
- Puerarin
Catalog No.:BCN5958
CAS No.:3681-99-0
- Isohemiphloin
Catalog No.:BCN5424
CAS No.:3682-02-8
- Naringenin triacetate
Catalog No.:BCN5425
CAS No.:3682-04-0
- 1,5-Pentanediol diacrylate
Catalog No.:BCC8426
CAS No.:36840-85-4
- Meclofenoxate hydrochloride
Catalog No.:BCC4170
CAS No.:3685-84-5
- Tramiprosate
Catalog No.:BCC7727
CAS No.:3687-18-1
- Aucuparin
Catalog No.:BCN7450
CAS No.:3687-28-3
- TC 14012
Catalog No.:BCC7910
CAS No.:368874-34-4
10-Shogaol, an antioxidant from Zingiber officinale for skin cell proliferation and migration enhancer.[Pubmed:22408422]
Int J Mol Sci. 2012;13(2):1762-77.
In this work, one of Zingiber officinale components, 10-Shogaol, was tested with 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging, metal chelating ability, and reducing power to show antioxidant activity. 10-Shogaol promoted human normal epidermal keratinocytes and dermal fibroblasts cell growths. 10-Shogaol enhanced growth factor production in transforming growth factor-beta (TGF-beta), platelet derived growth factor-alphabeta (PDGF-alphabeta) and vascular endothelial growth factors (VEGF) of both cells. In the in vitro wound healing assay for 12 or 24 h, with 10-Shogaol, the fibroblasts and keratinocytes migrated more rapidly than the vehicle control group. Thus, this study substantiates the target compound, 10-Shogaol, as an antioxidant for human skin cell growth and a migration enhancer with potential to be a novel wound repair agent.
Cysteine-conjugated metabolites of ginger components, shogaols, induce apoptosis through oxidative stress-mediated p53 pathway in human colon cancer cells.[Pubmed:24786146]
J Agric Food Chem. 2014 May 21;62(20):4632-42.
Shogaols, the major constituents of thermally processed ginger, have been proven to be highly effective anticancer agents. Our group has identified cysteine-conjugated shogaols (M2, M2', and M2'') as the major metabolites of [6]-, [8]-, and [10]-shogaol in human and found that M2 is a carrier of its parent molecule [6]-shogaol in cancer cells and in mice, while being less toxic to normal colon fibroblast cells. The objectives of this study are to determine whether M2' and M2'' behave in a similar manner to M2, in both metabolism and efficacy as anticancer agents, and to further explore the biological pro-apoptotic mechanisms of the cysteine-conjugated shogaols against human colon cancer cells HCT-116 and HT-29. Our results show that [8]- and [10]-shogaol have similar metabolic profiles to [6]-shogaol and exhibit similar toxicity toward human colon cancer cells. M2' and M2'' both show low toxicity against normal colon cells but retain potency against colon cancer cells, suggesting that they have similar activity to M2. We further demonstrate that the cysteine-conjugated shogaols can cause cancer cell death through the activation of the mitochondrial apoptotic pathway. Our results show that oxidative stress activates a p53 pathway that ultimately leads to p53 up-regulated modulator of apoptosis (PUMA) induction and down-regulation of B-cell lymphoma 2 (Bcl-2), followed by cytochrome c release, perturbation of inhibitory interactions of X-linked inhibitor of apoptosis protein (XIAP) with caspases, and finally caspase 9 and 3 activation and cleavage. A brief screen of the markers attenuated by the proapoptotic activity of M2 revealed similar results for [8]- and [10]-shogaol and their respective cysteine-conjugated metabolites M2' and M2''. This study highlights the cysteine-conjugated metabolites of shogaols as novel dietary colon cancer preventive agents.